Wu Ze-Yu, Wan Jin, Yao Yuan, Zhao Gang, Du Jia-Lin, Yang Jue
Department of General Surgery, Guangdong Provincial People's Hospital, Guangzhou 510080, China.
Zhonghua Wai Ke Za Zhi. 2008 Feb 1;46(3):190-2.
To evaluate the risk factors of lateral lymph node metastasis in advanced lower rectal cancer and its correlation with local recurrence and prognosis.
Data from 96 consecutive patients with advanced lower rectal cancer underwent curative surgery with lateral dissection were retrospectively analyzed. The correlations of lateral lymph node metastasis with clinicopathologic characteristics, local recurrence and prognosis were investigated.
Lateral lymph node metastasis was observed in 14.6 (14/96) of the cases. In 40 patients with tumor diameter > or = 5 cm, 10 (25.0%) patients were found with lateral lymph node metastasis; while in the other 56 patients, only 4 (7.1%) cases were found with lateral lymph node metastasis (P < 0.05). Lateral lymph node metastasis was more frequent in patients whose tumor infiltrated full range of the intestinal wall (70%) than patients with 3/4, 2/4 and 1/4 intestinal wall was infiltrated (12.0%, 6.7% and 6.3%, respectively) (P < 0.05). Lateral lymph node metastasis rate of poorly differentiated carcinomas was significantly higher than those of moderate and well-differentiated ones (30% vs. 9.1% and 4.5%, P < 0.05). Local recurrence occurred in 18.8% (18 of 96 cases) of patients. Local recurrence in patients with positive lateral lymph node metastasis was 64.3%, while 11.0% in those without lateral lymph node metastasis (P < 0.05). Kaplan-Meier survival analysis showed significant improvements in median survival for patients with negative lateral lymph node metastasis over patients with lateral lymph node metastasis (80.9 +/- 2.1 vs. 38 +/- 6.7 months, log-rank P < 0.05).
Tumor diameter, degree of tumor infiltration and histological differentiation are significant risk factors of lateral lymph node metastasis in advanced lower rectal cancer. Lateral lymph node metastasis is an important predictor of local recurrence and prognosis of patients.
评估晚期低位直肠癌侧方淋巴结转移的危险因素及其与局部复发和预后的相关性。
回顾性分析96例接受根治性手术并进行侧方清扫的晚期低位直肠癌患者的数据。研究侧方淋巴结转移与临床病理特征、局部复发和预后的相关性。
14.6%(14/96)的病例出现侧方淋巴结转移。在40例肿瘤直径≥5 cm的患者中,10例(25.0%)出现侧方淋巴结转移;而在其他56例患者中,仅4例(7.1%)出现侧方淋巴结转移(P<0.05)。肿瘤侵犯肠壁全层的患者侧方淋巴结转移更为常见(70%),高于肠壁侵犯3/4、2/4和1/4的患者(分别为12.0%、6.7%和6.3%)(P<0.05)。低分化癌的侧方淋巴结转移率显著高于中分化和高分化癌(30%对9.1%和4.5%,P<0.05)。18.8%(96例中的18例)的患者发生局部复发。侧方淋巴结转移阳性患者的局部复发率为64.3%,而侧方淋巴结转移阴性患者为11.0%(P<0.05)。Kaplan-Meier生存分析显示,侧方淋巴结转移阴性患者的中位生存期显著长于侧方淋巴结转移阳性患者(80.9±2.1对38±6.7个月,对数秩检验P<0.05)。
肿瘤直径、肿瘤浸润程度和组织学分化是晚期低位直肠癌侧方淋巴结转移的重要危险因素。侧方淋巴结转移是患者局部复发和预后的重要预测指标。